SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 535 filers reported holding SEAGEN INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $710,809 | +4.9% | 3,350 | -4.9% | 0.08% | +8.0% |
| Q2 2023 | $677,892 | -33.4% | 3,522 | -30.0% | 0.08% | -38.0% |
| Q1 2023 | $1,018,070 | +96.6% | 5,028 | +24.8% | 0.12% | +75.4% |
| Q4 2022 | $517,895 | +91.1% | 4,030 | +103.8% | 0.07% | +72.5% |
| Q3 2022 | $271,000 | -38.3% | 1,977 | -20.4% | 0.04% | -34.4% |
| Q2 2022 | $439,000 | +29.9% | 2,483 | +5.9% | 0.06% | +48.8% |
| Q1 2022 | $338,000 | -2.9% | 2,345 | +4.2% | 0.04% | -8.9% |
| Q4 2021 | $348,000 | -10.5% | 2,251 | -1.6% | 0.04% | -18.2% |
| Q3 2021 | $389,000 | +16.5% | 2,288 | +8.2% | 0.06% | +10.0% |
| Q2 2021 | $334,000 | +62.1% | 2,115 | +42.2% | 0.05% | -9.1% |
| Q1 2021 | $206,000 | -18.6% | 1,487 | +2.8% | 0.06% | -19.1% |
| Q4 2020 | $253,000 | – | 1,446 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |